Clinical Trial Update: realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

View source ↗

Summary

This ClinicalTrials.gov entry describes the realMIND observational study evaluating the safety and effectiveness of Tafasitamab in combination with Lenalidomide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Monjuvi (tafasitamab) (tafasitamab)
• Revlimid (lenalidomide) (lenalidomide)

Snippet

Sponsor: Incyte Corporation | Conditions: Diffuse Large B-cell Lymphoma | Status: RECRUITING